Organism: Saccharomyces cerevisiae
CellLine: crm1T539C mutant strain
CellLine: drg1-18 mutant
Bait: Bud20-TAP
MaterialType: pre-60S particles
SampleTreatment: treatment with leptomycin B (LmB)
SampleTreatment: treatment with diazaborine
SampleTreatment: ATPgammaS incubation
SampleTreatment: cryogenic freezing on Quantifoil grids
SampleTreatment: TEV protease cleavage
SampleTreatment: crosslinking with DSS-d0/DSS-d12 and BS3-d0/BS3-d12
Compound: ATPgammaS
Compound: diazaborine
Compound: leptomycin B (LmB)
ReductionReagent: DTT
AlkylationReagent: iodoacetamide
CleavageAgent: trypsin
Label: carbamidomethylation (fixed)
Label: oxidation of methionine
Modification: oxidation of methionine
Instrument: Orbitrap Fusion Tribrid mass spectrometer
IonizationType: electrospray ionization
AcquisitionMethod: liquid chromatography-tandem mass spectrometry (LC-MS/MS)
AcquisitionMethod: data-dependent acquisition (DDA)
FragmentationMethod: collision-induced dissociation (CID)
CollisionEnergy: 35% collision energy
MS2MassAnalyzer: Orbitrap
PrecursorMassTolerance: 10 ppm
EnrichmentMethod: size exclusion chromatography (SEC)
FractionationMethod: SEC using Superdex Peptide column
NumberOfFractions: four fractions
Separation: EASY-nLC 1200 system with 80-minute gradient
FlowRateChromatogram: 300 nL/min
AssayName: cryo-EM
AssayName: LC-MS/MS
AssayName: crosslinking mass spectrometry (XL-MS)
AssayName: SPR (surface plasmon resonance)
AssayName: ATPase activity assay
AssayName: GST pulldown
FactorValue: treatment condition (LmB, diazaborine, ATPgammaS)
FactorValue: wild-type vs Drg1 mutants (e.g. Drg1EQ1)
TechnicalReplicate: technical duplicates of four SEC fractions